Skip to main content
Ronald H.M.A. Bartels on Muck Rack

Ronald H.M.A. Bartels

As seen in: The Lancet, European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ronald H.M.A.

Contact Ronald H.M.A., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Transforaminal versus posterior lumbar interbody fusion for symptomatic single-level spondylolisthesis (LIFT): a multicentre controlled, patient blinded, randomised non-inferiority trial

|
By Kim Rijkers, Ronald H.M.A. Bartels, Mark Hulsbosch, Cicero Zorggroep
| The Lancet Verified
Research in context Our research team conducted two systematic reviews to compare Transforaminal Lumbar Interbody Fusion (TLIF) and Posterior Lumbar Interbody Fusion (PLIF). The first focused on effectiveness of TLIF versus PLIF. Searches were conducted in six databases, using the eligibility criteria; TLIF, PLIF, lumbar spondylolisthesis, disability, pain, complications, duration of surgery, blood loss. The search was conducted in September 2016.
Open in Who Shared Issue with article?

Clinical management of spinal metastases-The Dutch national guideline

|
By Amsterdam UMC, Laurens Bollen, Sander P.D. Dijkstra, Ronald H.M.A. Bartels
| European Journal of Cancer Verified
Publication History Published online: October 15, 2018Accepted: August 29, 2018; Received in revised form: August 22, 2018; Received: June 4, 2018;
Open in Who Shared Issue with article?
See all 2 articles